Comparison of Continuous Noninvasive and Invasive Intracranial Pressure Measurement--Celda Infusion Subprotocol

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
HydrocephalusShunt Malfunction
Interventions
DEVICE

Tympanic Membrane Displacement (TMD)

"The CCFP Analyser has a passive mode and an active mode. When used in active mode, the device generates a tone burst that is transmitted to the ear to elicit contraction of the stapedius muscle. The passive mode requires no stimulus or sound burst.~For each ICP level during the CSF infusion testing, the active mode will be used. Each condition comprises 13 stimuli of 0.3s duration."

DEVICE

DPOAE

DPOAE measurement uses a clinical acoustic probe to record the ear's response to two simultaneous tones. DPOAE measurements will be made for 13 tones. The total measurement time for each condition is 2-4 minutes.

Trial Locations (1)

Unknown

University of Umea Hospital, Umeå

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University Hospital, Umeå

OTHER

lead

LifeBridge Health

OTHER